Holen Sie sich die Stockscreener-App
0.3475
0.00%
0.00
Handel nachbörslich:
.35
0.0025
+0.72%
Schlusskurs vom Vortag:
$0.3475
Offen:
$0.3341
24-Stunden-Volumen:
932.09K
Relative Volume:
0.56
Marktkapitalisierung:
$5.29M
Einnahmen:
$486.00K
Nettoeinkommen (Verlust:
$-28.43M
KGV:
-0.1233
EPS:
-2.8189
Netto-Cashflow:
$-26.75M
1W Leistung:
-4.79%
1M Leistung:
-75.53%
6M Leistung:
-86.02%
1J Leistung:
-79.68%
1-Tages-Spanne:
$0.3341
$0.36
1-Wochen-Bereich:
$0.33
$0.4037
52-Wochen-Spanne:
$0.33
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Firmenname
Vyne Therapeutics Inc
Sektor
Branche
Telefon
800-775-7936
Adresse
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Vergleichen Sie VYNE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3475 | 5.79M | 486.00K | -28.43M | -26.75M | -2.8189 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-11-18 | Eingeleitet | BTIG Research | Buy |
| 2021-12-06 | Fortgesetzt | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten
Risk vs reward if holding onto VYNE Therapeutics Inc.Fed Meeting & Low Drawdown Trading Techniques - Newser
Is VYNE Therapeutics Inc. reversing from oversold territory2025 Key Lessons & Smart Money Movement Tracker - Newser
Is VYNE Therapeutics Inc. stock entering bullish territory2025 Top Gainers & Daily Price Action Insights - Newser
Is VYNE Therapeutics Inc. stock poised for growth [2025 Stock Rankings]Free Verified Short-Term Trading Plans - Newser
Is VYNE Therapeutics Inc. trending in predictive chart modelsConservative Investment Setup and Risk Analysis - Newser
Volume Surge May Signal Institutional Interest in VYNE Therapeutics Inc.Breakout Confirmation With Entry Tracker Enabled - 선데이타임즈
Technical analysis overview for VYNE Therapeutics Inc. stockSector Rotation and Stock Opportunity Analysis - Newser
What makes VYNE Therapeutics Inc. stock price move sharplyStrong ROI Equity Ideas - thegnnews.com
VYNE Therapeutics (VYNE) Projected to Post Quarterly Earnings on Wednesday - Defense World
Does VYNE Therapeutics Inc. stock pay reliable dividendsWeekly Breakout Forecast with Entry Zones - Newser
Does VYNE Therapeutics Inc. show high probability of reboundTechnical Trade Plan with Entry Checklist - Newser
Will earnings trigger a reversal in VYNE Therapeutics Inc.Free Weekly Hot Picks With Buy Confidence - Newser
Is VYNE Therapeutics Inc. stock poised for growthWeekly Portfolio Update with ROI Focus - Newser
Will breakout in VYNE Therapeutics Inc. lead to full recoveryRisk Aware Trading Ideas with Alert Levels - Newser
A Quick Look at Today's Ratings for VYNE Therapeutics(VYNE.US), With a Forecast Between $2 to $2 - 富途牛牛
Vyne Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
How to read the order book for VYNE Therapeutics Inc.Equity Performance Forecast Based on AI Models - Newser
Chart based exit strategy for VYNE Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser
How VYNE Therapeutics Inc. stock performs during market volatilityStock Trading Session Highlights and Summary - Newser
Real time pattern detection on VYNE Therapeutics Inc. stockFree Weekly Return Pick Forecast Reports - Newser
Elliott Wave Theory Predicts Pullback in VYNE Therapeutics Inc.Daily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
VYNE Therapeutics Stock Soars 13.31% on Long-Term Potential - AInvest
What are the latest earnings results for VYNE Therapeutics Inc.Master the art of timing market moves - Jammu Links News
When is VYNE Therapeutics Inc. stock expected to show significant growthCapitalize on momentum-driven opportunities - Jammu Links News
How volatile is VYNE Therapeutics Inc. stock compared to the marketTremendous return rates - Jammu Links News
Why is VYNE Therapeutics Inc. stock attracting strong analyst attentionPhenomenal wealth increase - Jammu Links News
Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):